SCHEMBL4975288

SCHEMBL4975288

Clc1ccccc1CN1CCc2ncnc(N3CCN(C4CCC4)CC3)c2CC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 2/20 0.44
HRH1 P35367 1/20 0.44
CNR1 P21554 2/20 0.44
TP53 P04637 1/20 0.43
ALDH1A1 P00352 5/20 0.42
PKM P14618 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
KDM4E B2RXH2 3/20 0.42
PLA2G1B P04054 1/20 0.42
RAB9A P51151 1/20 0.42
ATG4B Q9Y4P1 1/20 0.42
CNR2 P34972 1/20 0.42
MAPT P10636 2/20 0.41
HTT P42858 2/20 0.41
ABCB1 P08183 1/20 0.41
ABCG2 Q9UNQ0 1/20 0.41
TNKS O95271 1/20 0.41
PARP1 P09874 1/20 0.41
TNKS2 Q9H2K2 1/20 0.41
CXCR4 P61073 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4979833 0.93 TP53 (0.45) HRH3HRH1CNR1TP53ALDH1A1
SCHEMBL4976290 0.88 EPHX2 (0.44) HRH3HRH1CNR1ALDH1A1KDM4E
SCHEMBL4976029 0.88 HRH1 (0.44) HRH3HRH1CNR1ALDH1A1KDM4E
SCHEMBL4083239 0.88 HRH1 (0.47) HRH3HRH1ALDH1A1SMN1; SMN2KDM4E
SCHEMBL4976167 0.85 KMT2A (0.46) HRH3HRH1ALDH1A1TNKSPARP1
SCHEMBL4980306 0.83 HRH1 (0.54) HRH3HRH1TP53ALDH1A1SMN1; SMN2
SCHEMBL4976664 0.83 HRH1 (0.39) HRH3HRH1CNR1ALDH1A1KDM4E
SCHEMBL4978391 0.82 KDM4E (0.43) HRH3HRH1CNR1ALDH1A1KDM4E
SCHEMBL14346439 0.82 HRH3 (0.39) HRH3HRH1CNR1ALDH1A1KDM4E
SCHEMBL4981943 0.82 MEN1 (0.55) HRH3HRH1CNR1TP53ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES NEUROGEN CORPORATION 2008-02-28 US disclosed
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES NEUROGEN CORPORATION 2008-02-28 US disclosed
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES NEUROGEN CORPORATION 2008-02-28 US disclosed
WO-2007146122-A2 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES NEUROGEN CORPORATION (US) 2007-12-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080051387-A1 TETRAHYDROPYRIDO[3,4-D]PYRIMIDINES AND RELATED ANALOGUES HRH3, HRH4, HRH2 HRH3 1/4885HRH1 4/4885CNR1 65/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.